Paper8782831
Identification of NF1 mutations in both alleles of a dermal neurofibroma.
Sawada S and 5 others. Nat Genet, 1996. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Papers, record 8782831. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8782831
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neurofibromatosis 1 | Major topic |
| Proteins | Major topic |
| Sequence Deletion | Major topic |
| Alleles | |
| Amino Acid Sequence | |
| Base Sequence | |
| DNA Mutational Analysis | |
| DNA, Neoplasm | |
| Humans | |
| Molecular Sequence Data | |
| Neurofibromin 1 |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41564118 | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | PLoS One | 2026 | https://conductscience.org/library/papers/41564118 | PubMed |
| 40694332 | Ras-mediated dynamic and biphasic regulation of cell migration. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40694332 | PubMed |
| 38951708 | Ras suppression potentiates rear actomyosin contractility-driven cell polarization and migration. | Nat Cell Biol | 2024 | https://conductscience.org/library/papers/38951708 | PubMed |
| 38473354 | The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473354 | PubMed |
| 37627552 | The Contribution of Oxidative Stress to NF1-Altered Tumors. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37627552 | PubMed |
| 37318402 | Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1. | J Invest Dermatol | 2023 | https://conductscience.org/library/papers/37318402 | PubMed |
| 37245145 | RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. | J Invest Dermatol | 2023 | https://conductscience.org/library/papers/37245145 | PubMed |
| 28548933 | KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth. | Oncotarget | 2017 | https://conductscience.org/library/papers/28548933 | PubMed |
| 28067895 | The NF1 gene in tumor syndromes and melanoma. | Lab Invest | 2017 | https://conductscience.org/library/papers/28067895 | PubMed |
| 23700373 | Epidemiology and therapies for metastatic sarcoma. | Clin Epidemiol | 2013 | https://conductscience.org/library/papers/23700373 | PubMed |
| 22550514 | Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis. | Stem Cells Int | 2012 | https://conductscience.org/library/papers/22550514 | PubMed |
| 22155606 | Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. | Hum Genomics | 2011 | https://conductscience.org/library/papers/22155606 | PubMed |
| 21980365 | The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1. | PLoS One | 2011 | https://conductscience.org/library/papers/21980365 | PubMed |
| 21031597 | Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. | Hum Mutat | 2011 | https://conductscience.org/library/papers/21031597 | PubMed |
| 20958325 | Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. | Ann N Y Acad Sci | 2010 | https://conductscience.org/library/papers/20958325 | PubMed |
| 17879040 | Water-clear cell parathyroid adenoma causing primary hyperparathyroidism in a patient with neurofibromatosis type 1: report of a case. | Surg Today | 2007 | https://conductscience.org/library/papers/17879040 | PubMed |
| 17551851 | Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. | Fam Cancer | 2007 | https://conductscience.org/library/papers/17551851 | PubMed |
| 16961930 | Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR. | Mol Cancer | 2006 | https://conductscience.org/library/papers/16961930 | PubMed |
| 16835260 | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | Hum Mol Genet | 2006 | https://conductscience.org/library/papers/16835260 | PubMed |
| 16773574 | Double inactivation of NF1 in tibial pseudarthrosis. | Am J Hum Genet | 2006 | https://conductscience.org/library/papers/16773574 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NF1 | 4763 | PubTator's text mining | https://conductscience.org/library/genes/4763 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8782831
GET https://conductscience.org/api/papers/v1/8782831/cited_by?page=2